"Il Dr. Franco Gaboardi è uno dei pionieri della chirurgia urologica mininvasiva con tecnica laparoscopica e robotica. Si èspecializzato in Urologia ed Andrologia ha iniziato le prime esperienze laparoscopiche nel 1992 eseguendo la linfoadenectomia laparoscopica nel tumore prostatico.Nel Gennaio 2001 ha operato il primo paziente in Italia di prostatectomia radicale laparoscopica e nel settembre dello stesso anno il primo paziente di cistectomia radicale laparoscopica con neovescica ileale. Tre anni dopo eseguiva la prima prostatectomia radicale robotica in Italia e successivamente la prostatectomia laparoscopica con un solo accesso ombelicale (LESS)."

During the past decade, European Hospital conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 1 clinical trials were completed, i.e. on average, 6.3% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "European Hospital" #1 sponsor was "Cardiochirurgia E.H." with 9 trials, followed by "Edwards Lifesciences" with 2 trials sponsored, "European Hospital" with 2 trials sponsored, "Universita di Verona" with 2 trials sponsored and "Weill Medical College of Cornell University" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "European Hospital" #1 collaborator was "Andrea Salica" with 1 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator, "Cedars-Sinai Medical Center" with 1 trials as a collaborator, "Columbia University" with 1 trials as a collaborator and "Duke University" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "European Hospital" are "Coronary Artery Disease" (8 trials), "Blood Transfusion" (3 trials), "Aortic Valve Stenosis" (2 trials), "Atherosclerosis" (2 trials) and "Bleeding" (2 trials). Many other conditions were trialed in "European Hospital" in a lesser frequency.

Most popular intervention types in "European Hospital" are "Device" (12 trials), "Drug" (6 trials), "Procedure" (4 trials), "Behavioral" (2 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "HARPOON Beating Heart Mitral Valve Repair System (MVRS)" (2 trials), "Multiple arterial grafting" (2 trials), "Single arterial graft" (2 trials), "Aggregometry+Thromboelastography" (1 trials) and "Bare metal coronary stent" (1 trials). Other intervention names were less common.

The vast majority of trials in "European Hospital" are 20 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "European Hospital". 1 are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in European Hospital, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in European Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 14 trials that are defined as “Not Applicable".